Enzymatica AB (STU:EN9) Common Stock: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:EN9 Enzymatica AB STU:EN9
56 GF Score
Price €0.17
GF Value €0.16
! 3 Warning Signs
View Full Analysis

What is Enzymatica AB Common Stock?

Enzymatica AB STU:EN9 -7.73% 56 Common Stock is €0.00 Mil as of Jun. 2026. GuruFocus rates STU:EN9 with a GF Score™ of 56/100 and a GF Value™ of €0.16. The stock has 3 warning signs investors should review.

Enzymatica AB's quarterly common stock declined from Dec. 2025 (€0.89 Mil) to Mar. 2026 (€0.00 Mil) but then stayed the same from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€0.00 Mil).

Enzymatica AB's annual common stock increased from Dec. 2023 (€0.59 Mil) to Dec. 2024 (€0.84 Mil) and increased from Dec. 2024 (€0.84 Mil) to Dec. 2025 (€0.89 Mil).

Enzymatica AB Common Stock Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB Common Stock Chart

Enzymatica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.60 0.59 0.84 0.89

Enzymatica AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.89 0.00 0.00
STU:EN9
56GF Score
Enzymatica AB STU:EN9
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enzymatica AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.00 Mil mean?
Enzymatica AB (STU:EN9) has a Common Stock of €0.00 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Enzymatica AB and its competitors.
Is Enzymatica AB's Common Stock too high?
Enzymatica AB's current Common Stock is €0.00 Mil. Overall, Enzymatica AB has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Enzymatica AB's Common Stock compare to ZTS and UTHR?
Enzymatica AB's Common Stock of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Enzymatica AB and its competitors. Enzymatica AB's current Common Stock is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzymatica AB stock overvalued right now?
Enzymatica AB (STU:EN9) has a current Common Stock of €0.00 Mil. The stock's GF Value™ is €0.16, compared to a current price of €0.17 — trading 5.6% above its estimated fair value. The current Common Stock is €0.00 Mil. Enzymatica AB's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Enzymatica AB (STU:EN9), the current Common Stock is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (STU:EN9) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be overvalued. The current stock price of €0.17 is trading 5.6% above its estimated GF Value™ of €0.16.

Key valuation signals for STU:EN9:

  • Common Stock: €0.00 Mil
  • GF Value™: €0.16 vs. price of €0.17 (5.6% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the STU:EN9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enzymatica AB Business Description

Other Exchanges ENZY:SwedenEN9:Germany
Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
56GF Score

Get the complete analysis for STU:EN9

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.16
GF Value